CELC - Celcuity Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$157.67
DETAILS
HIGH:
$178.00
LOW:
$140.00
MEDIAN:
$155.00
CONSENSUS:
$157.67
UPSIDE:
139.62%
About Celcuity Inc. (https://www.celcuity.com)
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Brian F. Sullivan | Co-Founder, Chairman & Chief Executive Officer | 1962 | $945,218 USD |
| Lance G. Laing | Co-Founder, Chief Science Officer, Vice President, Secretary & Director | 1962 | $673,781 USD |
| Vicky Hahne | Chief Financial Officer | 1966 | $598,079 USD |
| Brent Eilefson | General Counsel & Chief Compliance Officer | – | – |
| Byron Robinson | Chief Strategy Officer | 1965 | – |
| Eldon C. Mayer | Chief Commercial Officer | 1961 | – |
| Igor Gorbatchevsky | Chief Medical Officer | – | – |
| Jodi Sievers | Head of Investor Relations & Corporate Communications | – | – |
| Sheri Smith | Acting Head of Clinical Operations | – | – |